Orchard Therapeutics plc (ORTX)
Jan 24, 2024 - ORTX was delisted (reason: acquired by Kyowa Kirin)
16.70
0.00 (0.00%)
Inactive · Last trade price
on Jan 23, 2024
Orchard Therapeutics Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$21.67
Upside
+29.76%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Stifel | Stifel | Strong Buy → Hold Downgrades $16 | Strong Buy → Hold | Downgrades | $16 | -4.19% | Oct 5, 2023 |
Oppenheimer | Oppenheimer | Buy Reiterates $34 | Buy | Reiterates | $34 | +103.59% | Aug 9, 2023 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $15 | Buy | Reiterates | $15 | -10.18% | Jun 27, 2023 |
Oppenheimer | Oppenheimer | Buy Maintains $37 → $34 | Buy | Maintains | $37 → $34 | +103.59% | Jun 13, 2023 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $3 → $15 | Buy | Maintains | $3 → $15 | -10.18% | Mar 28, 2023 |
Barclays | Barclays | Buy Maintains $60 → $40 | Buy | Maintains | $60 → $40 | +139.52% | May 13, 2022 |
SMBC Nikko | SMBC Nikko | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 1, 2022 |
Cowen & Co. | Cowen & Co. | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Mar 31, 2022 |
JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Nov 16, 2021 |
Oppenheimer | Oppenheimer | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 5, 2021 |
JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 18, 2021 |
JP Morgan | JP Morgan | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 2, 2021 |
Oppenheimer | Oppenheimer | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Apr 1, 2020 |
Cowen & Co. | Cowen & Co. | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 26, 2018 |